These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6084823)

  • 21. Aminergic systems in Alzheimer's disease and Parkinson's disease.
    D'Amato RJ; Zweig RM; Whitehouse PJ; Wenk GL; Singer HS; Mayeux R; Price DL; Snyder SH
    Ann Neurol; 1987 Aug; 22(2):229-36. PubMed ID: 3477996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The concept of serotonergic depression].
    Plaisant O; Leboyer M; Debray Q; Pelicier Y
    Ann Med Interne (Paris); 1983; 134(8):691-4. PubMed ID: 6198949
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
    Arai H; Ichimiya Y; Kosaka K; Moroji T; Iizuka R
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):883-90. PubMed ID: 1381103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.
    Cross AJ; Crow TJ; Johnson JA; Perry EK; Perry RH; Blessed G; Tomlinson BE
    J Neurol Sci; 1984 May; 64(2):109-17. PubMed ID: 6747659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin concentrations and turnover in brains of depressed suicides.
    Cheetham SC; Crompton MR; Czudek C; Horton RW; Katona CL; Reynolds GP
    Brain Res; 1989 Nov; 502(2):332-40. PubMed ID: 2479456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmortem neurochemical studies in depression.
    Ferrier IN; McKeith IG; Cross AJ; Perry EK; Candy JM; Perry RH
    Ann N Y Acad Sci; 1986; 487():128-42. PubMed ID: 2436529
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide.
    Gross-Isseroff R; Israeli M; Biegon A
    Arch Gen Psychiatry; 1989 Mar; 46(3):237-41. PubMed ID: 2537613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.
    Cross AJ; Crow TJ; Ferrier IN; Johnson JA
    Neurobiol Aging; 1986; 7(1):3-7. PubMed ID: 2869422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM; Janssen PF; Leysen JE
    Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain 5-HT2 receptor binding sites in depressed suicide victims.
    Cheetham SC; Crompton MR; Katona CL; Horton RW
    Brain Res; 1988 Mar; 443(1-2):272-80. PubMed ID: 3359270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurotransmitter abnormalities in the dementia of Alzheimer type].
    Sasaki H; Arai H
    Rinsho Shinkeigaku; 1986 Dec; 26(12):1290-3. PubMed ID: 2881639
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala.
    Hrdina PD; Demeter E; Vu TB; Sótónyi P; Palkovits M
    Brain Res; 1993 Jun; 614(1-2):37-44. PubMed ID: 8348328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
    Perry EK; Perry RH; Candy JM; Fairbairn AF; Blessed G; Dick DJ; Tomlinson BE
    Neurosci Lett; 1984 Oct; 51(3):353-7. PubMed ID: 6521962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex.
    Harkany T; O'Mahony S; Keijser J; Kelly JP; Kónya C; Borostyánkoi ZA; Görcs TJ; Zarándi M; Penke B; Leonard BE; Luiten PG
    Neurobiol Dis; 2001 Aug; 8(4):667-78. PubMed ID: 11493031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.
    Wouters W; Janssen CG; Van Dun J; Thijssen JB; Laduron PM
    J Med Chem; 1986 Sep; 29(9):1663-8. PubMed ID: 3746815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic and noradrenergic neurobiology of alcoholic suicide.
    Underwood MD; Mann JJ; Arango V
    Alcohol Clin Exp Res; 2004 May; 28(5 Suppl):57S-69S. PubMed ID: 15166637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.
    Goodwin FK; Post RM
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):393S-405S. PubMed ID: 6190490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.